Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bespoke ExtractsBSPK Days Payable is 0.00 as of Sep. 2025. The stock has 3 warning signs investors should review. Among 927 Drug Manufacturers companies, Bespoke Extracts ranks better than 95.79% on this metric.
The historical rank and industry rank for Bespoke Extracts's Days Payable or its related term are showing as below:
BSPK'
s Days Payable Range Over the Past 10 Years
Min: 0 Med: 0 Max: 673.7
Current: 673.7
During the past 13 years, Bespoke Extracts's highest Days Payable was 673.70. The lowest was 0.00. And the median was 0.00.
BSPK's Days Payable is ranked better than 95.79% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.28
vs BSPK: 673.70
Bespoke Extracts's Days Payable
declined
from Sep. 2024 (781.82) to Sep. 2025 (0.00).
It may suggest that Bespoke Extractsaccelerated paying its suppliers.
The historical data trend for Bespoke Extracts's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Bespoke Extracts's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bespoke Extracts Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bespoke Extracts's Days Payable distribution charts can be found below:
* The bar in red indicates where Bespoke Extracts's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Bespoke Extracts's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bespoke Extracts (BSPK) has a Days Payable of 0.00 as of Sep. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bespoke Extracts and its competitors. According to the industry distribution chart, Bespoke Extracts ranks #39 out of 927 companies in the Drug Manufacturers industry, placing it in the top 4.2%.
Is Bespoke Extracts' Days Payable too high?
Bespoke Extracts' current Days Payable is 0.00. Based on the distribution chart, Bespoke Extracts ranks #39 out of 927 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Bespoke Extracts' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Bespoke Extracts ranks #39 out of 927 companies for Days Payable. This places Bespoke Extracts in the top 4% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.28, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bespoke Extracts and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bespoke Extracts's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bespoke Extracts stock overvalued right now?
Bespoke Extracts (BSPK) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bespoke Extracts (BSPK), the current Days Payable is 0.00 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, quality, hemp-derived CBD products. The company owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including Fresh Joints, Doobskis, DutchBlunts, and Wee Joints, to licensed marijuana dispensaries across Colorado.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSPK has been successfully added to your 
